Handelsavisen
prelaunch
Companies Industrials ONMD.O
ON
ONMD.O NASDAQ Industrial Support Services

Onemednet Corp

$0,73
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
38,0M USD
P/E
EV / Rev
39,1x
Div yield
Op margin
-847,2 %
ROE
13,4 %
Net margin
-850,4 %
Debt / equity
-0,24
Beta
52w range
Volume
4,8k
Day range
$0,79–$0,85
Prev close
$0,85
Open
$0,85
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Onemednet Corp provides industrial services, primarily in the health care technology sector, generating revenue through its operations in business support services.

Business. Onemednet Corp (ONMD.O) is a business support services company operating within the Industrial & Commercial Services sector. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification99 %
SectorIndustrials
Industry groupIndustrial Support Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
Vanguard Capital Management, LLC
largest disclosed fund holder
Profitability
13,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ONMD.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ONMD.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Onemednet Corp (ONMD.O) is a business support services company operating within the Industrial & Commercial Services sector. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification99 %
    SectorIndustrials
    Industry groupIndustrial Support Services
    AI synthesis
    GENERATED

    Onemednet Corp's capital structure is highly leveraged, with total liabilities of $16.45 million and total equity of -$15.70 million, indicating a negative net worth. The company's liquidity position is weak, as reflected by a current ratio of 0.04, suggesting significant short-term financial stress. The enterprise value to revenue ratio of 214.24 is well above the typical range for the industry, indicating a high valuation relative to its revenue base.

    Profitability metrics are deeply negative, with a net income of -$2.11 million and an operating income of -$2.10 million. The return on equity of 0.1343 is misleading due to the negative equity base, and the return on assets of -2.812 indicates poor asset utilization. These figures are far below the industry median for profitability and returns, suggesting a company in distress.

    The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to sector-specific risks and limits the company's ability to offset losses in one area with gains in another.

    Growth trajectory is negative, with no clear signs of improvement in the current fiscal year. The company's operating cash flow is -$1.55 million, and free cash flow is -$2.10 million, indicating a lack of internal cash generation. The capital expenditure of -$6,000 suggests minimal investment in future growth, further signaling a lack of strategic direction.

    Risk factors include a high liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, but the company's negative equity and high debt levels could lead to future dilution if additional financing is required. No recent events or filings have been disclosed that would indicate a change in the company's risk profile.

    Recent events and filings do not show any significant developments that would alter the company's current financial or operational status. The absence of recent positive news or strategic moves suggests a lack of momentum and potential for recovery.

    Key takeaways
    • Onemednet Corp is operating at a significant loss, with a negative net income and operating income.
    • The company's capital structure is highly leveraged, with total liabilities exceeding total assets.
    • The company's liquidity position is weak, as indicated by a very low current ratio.
    • The company's valuation is extremely high relative to its revenue, suggesting a disconnect between market perception and financial performance.
    • The company lacks geographic and segment diversification, increasing its exposure to sector-specific risks.
    • The company's growth trajectory is negative, with no signs of improvement in the current fiscal year.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Revenue surged 111.4% year-over-year to $1.36 million, demonstrating significant top-line growth momentum in the latest fiscal period.

    Net income improved by 72.3% year-over-year, indicating a substantial reduction in losses compared to the prior fiscal year.

    Free cash flow improved by 57.8% year-over-year, reflecting better cash generation capabilities despite ongoing negative flows.

    Dilution risk is assessed as low, providing some stability for existing shareholders regarding potential equity issuance impacts.

    BEAR CASE · 5

    The company faces high credit risk and medium liquidity risk, signaling potential difficulties in meeting short-term financial obligations.

    Operating margin of -8.47% places the company in the bottom quartile of its business support services cohort.

    Net margin of -8.50% ranks in the bottom quartile among 381 peers, highlighting persistent profitability challenges.

    A current ratio of 0.43 indicates severe liquidity constraints, as current assets cover less than half of current liabilities.

    Cash conversion of 0.73 is below the cohort median of 1.15, suggesting weaker efficiency in converting earnings to cash.

    In focus — financials by report

    Valuation FY

    Market price
    $0,73
    Market cap
    $49.3M
    Enterprise value
    $53.1M
    P/E
    Non-GAAP P/E
    EV / Revenue
    39.1x
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    -$15.7M
    Net cash
    -$3.8M
    Current ratio
    0.0
    Debt / equity
    -0.2
    ROA
    -2.8%
    ROE
    13.4%
    Cash conversion
    73.0%
    CapEx / revenue
    -2.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYIndustrialsIndustryIndustrial Support Services31,7B node revenueRTO 21,8%FCN 11,9%ROL 11,8%URI 11,6%ULS 9,6%GEO 8,3%EQPT 6,4%TIC 4,8%Other 13,6%
    Source: company disclosures · own-taxonomy revenue-covered setONMD 0,0% · rank #27 of 31

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs ONMD · multiples and returns
    RT
    RTO
    Rentokil Initial PLC
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    FC
    FCN
    Fti Consulting Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    RO
    ROL
    Rollins Inc
    $38,19
    18,4B USD
    P/E
    36,0x
    vs self
    Div yield
    1,7 %
    vs self
    ROE
    38,1 %
    +24,7 vs self
    UR
    URI
    United Rentals Inc
    $1 115,92
    70,3B USD
    P/E
    28,6x
    vs self
    Div yield
    0,6 %
    vs self
    ROE
    27,8 %
    +14,4 vs self
    UL
    ULS
    Ul Solutions Inc
    $91,05
    18,3B USD
    P/E
    57,3x
    vs self
    Div yield
    0,6 %
    vs self
    ROE
    25,8 %
    +12,3 vs self
    GE
    GEO
    Geo Group Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    EQ
    EQPT
    Equipmentshare.Com Inc
    $20,20
    4,6B USD
    P/E
    126,5x
    vs self
    Div yield
    vs self
    ROE
    3,3 %
    -10,1 vs self
    TI
    TIC
    Tic Solutions Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-847,2 %Bottom quartile
    Net Margin-850,4 %Bottom quartile
    ROE13,4 %Above median
    Capex / Rev-2,4 %Above median
    D/E-0,24Above P75
    Cash Conv0,73Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • Onemednet Corp Market data — financials · 2026-05-28

    Ownership & reference

    Top holders

    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$1M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Aaron GreenPresident, Chief Executive Officer, Director

    Insider activity

    Net buying30 buys · 2 sellsnet $2,7M9 insiders · last 365d
    • Green AaronDirector, Chief Executive Officer · Common StockBought 36 650 @ $0,57$21K · 2026-06-23
    • Yu JeffreyDirector, Chief Medical Officer, 10% owner · Common StockBought 158 730 @ $0,63$100K · 2026-06-23
    • Yu JeffreyDirector, Chief Medical Officer, 10% owner · Common StockBought 172 414 @ $0,58$100K · 2026-06-16
    • Green AaronDirector, Chief Executive Officer · Common StockBought 18 702 @ $0,54$10K · 2026-06-15
    • Green AaronDirector, Chief Executive Officer · Common StockBought 36 920 @ $0,56$21K · 2026-06-12
    • Kosasa ThomasDirector, 10% owner · Common StockBought 158 730 @ $0,63$100K · 2026-06-12
    • Kosasa ThomasDirector, 10% owner · Common StockBought 268 817 @ $0,93$250K · 2026-05-18
    • Kosasa ThomasDirector, 10% owner · Common StockBought 280 898 @ $0,89$250K · 2026-04-23
    • Yu JeffreyDirector, Chief Medical Officer, 10% owner · Common StockBought 903 614 @ $0,83$750K · 2026-04-01
    • Yu JeffreyDirector, Chief Medical Officer, 10% owner · Common StockOther 219 429 @ $0,83$182K · 2026-04-01
    • Kosasa ThomasDirector, 10% owner · Common StockBought 595 238 @ $0,84$500K · 2026-02-06
    • Golden Robert LawrenceDirector, Chief Financial Officer · Common StockOther 45 000 · 2025-11-26
    • Alleyne KennethDirector · Common StockOther 38 219 · 2025-11-26
    • Zeinfeld Andrew BDirector · Common StockOther 45 000 · 2025-11-26
    • Clarke JairDirector · Common StockOther 45 000 · 2025-11-26
    • Kosasa ThomasDirector · Common StockOther 45 000 · 2025-11-26
    • Yu JeffreyDirector, Chief Medical Officer · Common StockOther 45 000 · 2025-11-26
    • McCraw Sherry CoonseDirector · Common StockOther 45 000 · 2025-11-26
    • Green AaronDirector, Chief Executive Officer · Common StockOther 45 000 · 2025-11-26
    • Casaburi EricDirector · Common StockOther 45 000 · 2025-11-26
    • Golden Robert LawrenceDirector, Chief Financial Officer · Common StockOther 300 000 · 2025-11-24
    • Yu JeffreyDirector, Chief Medical Officer · Common StockOther 200 000 · 2025-11-24
    • Golden Robert LawrenceDirector, Chief Financial Officer · Common StockOther 33 333 · 2025-11-24
    • Green AaronDirector, Chief Executive Officer · Common StockOther 1 000 000 · 2025-11-24
    • Green AaronDirector, Chief Executive Officer · Common StockSold 61 555 @ $1,20$74K · 2025-11-18

    Short positioning

    345.5Kshares short+48.4% vs prior
    2.75days to cover
    35.1%short of daily vol
    19.7Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ONMD.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -0.6%Derived (calculated)
    • Net margin (FY 2025-12-31): -206.1%Derived (calculated)
    • Gross margin (FY 2025-12-31): -37.0%Derived (calculated)
    • Return on equity (FY 2025-12-31): 94.5%Derived (calculated)
    • Return on assets (FY 2025-12-31): -130.2%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.43xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): -1.73xDerived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -74.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 240.1%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 101.5%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 83.3%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 83.3%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): -79.0%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 72.3%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -7.9%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 3.3%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 111.4%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 81.4%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -42.3%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -74.0%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -90.5%Derived (calculated)
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Total operating expenses (annual): USD 9.16MSEC XBRL filing
    • Pre-tax income (annual): USD -2.8MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: insider_flow_signal (90d)
    2026-06-23 00:00 UTCINSIDER6 insider transactions — 2026-06 · net buy $352k
    2026-06-23INSIDERGreen Aaron bought 36.6k sh — Director, Chief Executive Officer ~$21k
    2026-06-23INSIDERYu Jeffrey bought 158.7k sh — Director, Chief Medical Officer, 10% owner ~$100k
    2026-06-16INSIDERYu Jeffrey bought 172.4k sh — Director, Chief Medical Officer, 10% owner ~$100k
    2026-06-15INSIDERGreen Aaron bought 18.7k sh — Director, Chief Executive Officer ~$10k
    2026-06-12INSIDERGreen Aaron bought 36.9k sh — Director, Chief Executive Officer ~$21k
    2026-06-12INSIDERKosasa Thomas bought 158.7k sh — Director, 10% owner ~$100k
    2026-05-18 00:00 UTCINSIDER1 insider transaction — 2026-05 · net buy $250k
    2026-05-18INSIDERKosasa Thomas bought 268.8k sh — Director, 10% owner ~$250k
    2026-05-15FILING424B3 filing →
    2026-05-15FILING10-Q filing →
    2026-04-23 00:00 UTCINSIDER3 insider transactions — 2026-04 · net buy $1.2M
    2026-04-23INSIDERKosasa Thomas bought 280.9k sh — Director, 10% owner ~$250k
    2026-04-20FILING8-K filing →
    2026-04-01INSIDERYu Jeffrey bought 903.6k sh — Director, Chief Medical Officer, 10% owner ~$750k
    2026-04-01INSIDERYu Jeffrey transacted 219.4k sh — Director, Chief Medical Officer, 10% owner ~$182k
    2026-03-31FILING424B3 filing →
    2026-03-30FILING10-K filing →
    2026-02-06 00:00 UTCINSIDER1 insider transaction — 2026-02 · net buy $500k
    2026-02-06INSIDERKosasa Thomas bought 595.2k sh — Director, 10% owner ~$500k
    2025-12-23FILING8-K filing →
    2025-11-26 00:00 UTCINSIDER14 insider transactions — 2025-11
    2025-11-26INSIDERGolden Robert Lawrence transacted 45.0k sh — Director, Chief Financial Officer
    2025-11-26INSIDERAlleyne Kenneth transacted 38.2k sh — Director
    2025-11-26INSIDERZeinfeld Andrew B transacted 45.0k sh — Director
    2025-11-26INSIDERClarke Jair transacted 45.0k sh — Director
    2025-11-26INSIDERKosasa Thomas transacted 45.0k sh — Director
    2025-11-26INSIDERYu Jeffrey transacted 45.0k sh — Director, Chief Medical Officer
    2025-11-26INSIDERMcCraw Sherry Coonse transacted 45.0k sh — Director
    2025-11-26INSIDERGreen Aaron transacted 45.0k sh — Director, Chief Executive Officer
    2025-11-26INSIDERCasaburi Eric transacted 45.0k sh — Director
    2025-11-24INSIDERGolden Robert Lawrence transacted 300.0k sh — Director, Chief Financial Officer
    2025-11-24INSIDERYu Jeffrey transacted 200.0k sh — Director, Chief Medical Officer
    2025-11-24INSIDERGolden Robert Lawrence transacted 33.3k sh — Director, Chief Financial Officer
    2025-11-24INSIDERGreen Aaron transacted 1.00M sh — Director, Chief Executive Officer
    2025-11-18INSIDERGreen Aaron sold 61.6k sh — Director, Chief Executive Officer ~$74k
    2025-11-14FILING424B3 filing →
    2025-11-14FILING10-Q filing →
    Showing the 40 most recent of 47 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage